- Home
- MVSTW vs SMTI Comparison
MVSTW vs SMTI Comparison
Compare MVSTW & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVSTW
- SMTI
- Stock Information
- Founded
- MVSTW 2006
- SMTI 1982
- Country
- MVSTW United States
- SMTI United States
- Employees
- MVSTW 1921
- SMTI N/A
- Industry
- MVSTW Industrial Machinery/Components
- SMTI Medical/Dental Instruments
- Sector
- MVSTW Miscellaneous
- SMTI Health Care
- Exchange
- MVSTW Nasdaq
- SMTI Nasdaq
- Market Cap
- MVSTW N/A
- SMTI 266.7M
- IPO Year
- MVSTW N/A
- SMTI N/A
- Fundamental
- Price
- MVSTW $0.21
- SMTI $32.14
- Analyst Decision
- MVSTW
- SMTI Strong Buy
- Analyst Count
- MVSTW 0
- SMTI 2
- Target Price
- MVSTW N/A
- SMTI $48.50
- AVG Volume (30 Days)
- MVSTW 126.0K
- SMTI 33.4K
- Earning Date
- MVSTW 03-14-2025
- SMTI 05-14-2025
- Dividend Yield
- MVSTW N/A
- SMTI N/A
- EPS Growth
- MVSTW N/A
- SMTI N/A
- EPS
- MVSTW N/A
- SMTI N/A
- Revenue
- MVSTW $370,989,000.00
- SMTI $86,672,425.00
- Revenue This Year
- MVSTW N/A
- SMTI $23.68
- Revenue Next Year
- MVSTW N/A
- SMTI $5.80
- P/E Ratio
- MVSTW N/A
- SMTI N/A
- Revenue Growth
- MVSTW 39.03
- SMTI 33.36
- 52 Week Low
- MVSTW $0.35
- SMTI $25.86
- 52 Week High
- MVSTW $0.44
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- MVSTW N/A
- SMTI 56.95
- Support Level
- MVSTW N/A
- SMTI $28.17
- Resistance Level
- MVSTW N/A
- SMTI $32.24
- Average True Range (ATR)
- MVSTW 0.00
- SMTI 1.59
- MACD
- MVSTW 0.00
- SMTI 0.51
- Stochastic Oscillator
- MVSTW 0.00
- SMTI 96.02
About MVSTW Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.